Journal of Clinical Endocrinology & Metabolism, Vol 63, 747-750, Copyright © 1986 by Endocrine Society

ARTICLES

Metoclopramide increases vasopressin secretion

G Norbiato, M Bevilacqua, E Chebat, P Bertora, P Cavaiani, C Baruto, S Fumagalli and U Raggi

The possibility that metoclopramide (MCP), a potent stimulator of aldosterone secretion, might influence vasopressin secretion in man was studied. MCP (10 mg, iv) increased plasma vasopressin (mean +/- SD) from 1.3 +/- 0.1 to 2.4 +/- 0.1 pg/ml at 10 min and to 2.65 +/- 0.1 pg/ml at 20 min (P less than 0.01) in 10 recumbent normal subjects. No changes in plasma osmolality or peripheral hemodynamics, which might have accounted for the increase in vasopressin, were found. Sulpiride (100 mg iv), haloperidol (2 mg, iv), and domperidone (20 mg, iv), three chemically unrelated antidopaminergic agents, as well as TRH (200 micrograms, iv), failed to modify plasma vasopressin, thus suggesting that the MCP effect on vasopressin is not linked to its antidopaminergic and/or PRL-releasing properties. MCP also was effective in releasing vasopressin in 5 dehydrated subjects, in whom plasma vasopressin increased from 1.9 +/- 0.2 to 3.1 +/- 4 pg/ml (P less than 0.05), and in 5 subjects during steady state water diuresis, in whom free water excretion decreased from 9 to 1 ml/min (P less than 0.01) and plasma vasopressin increased from 0.3 +/- 0.1 to 1.2 +/- 0.2 pg/ml (P less than 0.05). No changes in either vasopressin secretion or free water excretion occurred in 4 patients with severe central diabetes insipidus. These results suggest that MCP stimulates the release of biologically active vasopressin in man.

This article has been cited by other articles:

				T. Ozawa, H. Tanaka, R. Nakano, M. Sato, T. Inuzuka, Y. Soma, N. Yoshimura, N. Fukuhara, and S. Tsuji Nocturnal decrease in vasopressin secretion into plasma in patients with multiple system atrophy J. Neurol. Neurosurg. Psychiatry, October 1, 1999; 67(4): 542 - 545. [Abstract] [Full Text] [PDF]